These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18816410)

  • 1. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
    Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
    J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of mSurvivinThr34→Ala in murine colon carcinoma when administered intravenously.
    Li HX; Zhao XY; Wang L; Wang YS; Kan B; Xu JR; Li J; Wen YJ; Peng XC; Chen X; Yan F; Ye B; Du XB; Zhao JM; Yi T; Chen XC; Du XX; Wei YQ; Zhao X
    Med Oncol; 2010 Dec; 27(4):1156-63. PubMed ID: 19949901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.
    Pan L; Peng XC; Leng F; Yuan QZ; Shan Y; Yu DD; Li ZY; Chen X; Xiao WJ; Wen Y; Ma TT; Yang L; Mao YQ; Yang HS; Wei YQ; Wang CT
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):19-28. PubMed ID: 20217127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administration.
    Shan Y; Wang C; Yang L; Chen LJ; Deng HX; Yang HS; Li Z; Li Z; Pan L; Leng F; Wei Y
    J Biosci; 2010 Jun; 35(2):209-16. PubMed ID: 20689177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced tumor radiosensitivity by a survivin dominant-negative mutant.
    Yuan QZ; Wang CT; Mao YQ; Zhang P; Shi HS; Li ZY; Pan L; Yu DD; Leng F; Chen X; Ying W; Xu JH; Li W; Wu F; Wen Y; Ma TT; Wei YQ
    Oncol Rep; 2010 Jan; 23(1):97-103. PubMed ID: 19956869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
    Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
    Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant.
    Yu DD; Wang CT; Shi HS; Li ZY; Pan L; Yuan QZ; Leng F; Wen Y; Chen X; Wei YQ
    J Exp Clin Cancer Res; 2010 May; 29(1):46. PubMed ID: 20462440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].
    Pan L; Peng XC; Yuan QZ; Leng F; Yu DD; Shan Y; Li ZY; Wang CT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):390-3. PubMed ID: 20629305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lymphatic metastases by a survivin dominant-negative mutant.
    Xu GC; Zhang P; Leng F; Pan L; Li ZY; Yu DD; Shan Y; Yuan QZ; Wen Y; Mu B; Shi HS; Chen X; Wang CT
    Oncol Res; 2012; 20(12):579-87. PubMed ID: 24139416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor and antimetastatic activities of plasmid pcDNA3. 1-IP10 complexed with cationic liposome in mice with 4T1 breast cancer].
    Tang QQ; Shi W; Lü HM; Peng XC; Wen YJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):195-8. PubMed ID: 19462888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-tumor effects of recombinant adenovirus encoding survivin encapsulated in cationic liposome].
    Yang YL; Ding ZY; Li Q; Zhou H; Deng HX; Tian L; Wei YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):704-7. PubMed ID: 17037732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
    Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z
    Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
    Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
    Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
    Huang A; Yue D; Liao D; Cheng L; Ma J; Wei Y; Tong A; Cheng P
    Oncol Rep; 2016 Dec; 36(6):3283-3290. PubMed ID: 27748945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Survivin-T34A mutant on breast cancer cell in vitro and in vivo].
    Deng X; Song H; Ren M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Jun; 31(3):648-51. PubMed ID: 25219251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers.
    Vaidya S; Mohod A; Eedara AC; Andugulapati SB; Pabbaraja S
    ChemMedChem; 2023 Aug; 18(16):e202300097. PubMed ID: 37306531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonviral vector for efficient gene transfer to human ovarian adenocarcinoma cells.
    Kim CK; Haider KH; Choi SH; Choi EJ; Ahn WS; Kim YB
    Gynecol Oncol; 2002 Jan; 84(1):85-93. PubMed ID: 11748982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model.
    Alipour Talesh G; Ebrahimi Z; Badiee A; Mansourian M; Attar H; Arabi L; Jalali SA; Jaafari MR
    Immunol Lett; 2016 Aug; 176():57-64. PubMed ID: 27260485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-mediated DNA immunisation via the subcutaneous route.
    Perrie Y; McNeil S; Vangala A
    J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.